Validated method for determination of bromopride in human plasma by liquid chromatography--electrospray tandem mass spectrometry: application to the bioequivalence study

J Mass Spectrom. 2005 Sep;40(9):1197-202. doi: 10.1002/jms.898.

Abstract

A simple, sensitive and specific liquid chromatography-tandem mass spectrometry method for the quantification of bromopride I in human plasma is presented. Sample preparation consisted of the addition of procainamide II as the internal standard, liquid-liquid extraction in alkaline conditions using hexane-ethyl acetate (1 : 1, v/v) as the extracting solvent, followed by centrifugation, evaporation of the solvent and sample reconstitution in acetonitrile. Both I and II (internal standard, IS) were analyzed using a C18 column and the mobile-phase acetonitrile-water (formic acid 0.1%). The eluted compounds were monitored using electrospray tandem mass spectrometry. The analyses were carried out by multiple reaction monitoring (MRM) using the parent-to-daughter combinations of m/z 344.20 > 271.00 and m/z 236.30 > 163.10. The areas of peaks from analyte and IS were used for quantification of I. The achieved limit of quantification was 1.0 ng/ml and the assay exhibited a linear dynamic range of 1-100.0 ng/ml and gave a correlation coefficient (r) of 0.995 or better. Validation results on linearity, specificity, accuracy, precision and stability, as well as application to the analysis of samples taken up to 24 h after oral administration of 10 mg of I in healthy volunteers demonstrated the applicability to bioequivalence studies.

Publication types

  • Validation Study

MeSH terms

  • Chromatography, High Pressure Liquid*
  • Dopamine Antagonists / blood*
  • Dopamine Antagonists / pharmacokinetics*
  • Humans
  • Metoclopramide / analogs & derivatives*
  • Metoclopramide / blood
  • Metoclopramide / pharmacokinetics
  • Spectrometry, Mass, Electrospray Ionization / methods*
  • Therapeutic Equivalency

Substances

  • Dopamine Antagonists
  • bromopride
  • Metoclopramide